Predictive value of early interim FDG-PET according to stage and extranodal disease
. | PET2 (qualitative) . | . | . | |
---|---|---|---|---|
. | Negative . | Positive . | Total . | |
Early stage (I-IIA) | ||||
Progression | ||||
No | 26 | 4 | 30 | |
Yes | 0 | 1 | 1 | |
Total | 26 | 5 | 31 | |
Advanced stage (IIB-IV) | ||||
Progression | ||||
No | 32 | 1 | 33 | |
Yes | 3 | 10 | 13 | |
Total | 35 | 11 | 46 | |
No extranodal disease | ||||
Progression | ||||
No | 51 | 5 | 56 | |
Yes | 3 | 4 | 7 | |
Total | 54 | 9 | 63 | |
Extranodal disease | ||||
Progression | ||||
No | 7 | 0 | 7 | |
Yes | 0 | 7 | 7 | |
Total | 35 | 7 | 14 |
. | PET2 (qualitative) . | . | . | |
---|---|---|---|---|
. | Negative . | Positive . | Total . | |
Early stage (I-IIA) | ||||
Progression | ||||
No | 26 | 4 | 30 | |
Yes | 0 | 1 | 1 | |
Total | 26 | 5 | 31 | |
Advanced stage (IIB-IV) | ||||
Progression | ||||
No | 32 | 1 | 33 | |
Yes | 3 | 10 | 13 | |
Total | 35 | 11 | 46 | |
No extranodal disease | ||||
Progression | ||||
No | 51 | 5 | 56 | |
Yes | 3 | 4 | 7 | |
Total | 54 | 9 | 63 | |
Extranodal disease | ||||
Progression | ||||
No | 7 | 0 | 7 | |
Yes | 0 | 7 | 7 | |
Total | 35 | 7 | 14 |